Edition:
United States

Biohit Oyj (BIOBV.HE)

BIOBV.HE on Helsinki Stock Exchange

5.45EUR
10:41am EDT
Change (% chg)

€0.00 (+0.00%)
Prev Close
€5.45
Open
€5.44
Day's High
€5.45
Day's Low
€5.42
Volume
6,460
Avg. Vol
10,074
52-wk High
€6.85
52-wk Low
€4.71

BIOBV.HE

Chart for BIOBV.HE

About

Biohit Oyj is a Finland-based company engaged in the development, manufacture and marketing of diagnostic tests and analysis systems. The Company operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. It provides blood-sample... (more)
No analyst recommendations are available for BIOBV.HE.

Overall

Beta: 0.98
Market Cap(Mil.): €63.89
Shares Outstanding(Mil.): 11.72
Dividend: --
Yield (%): --

Financials

  BIOBV.HE Industry Sector
P/E (TTM): -- 29.24 29.98
EPS (TTM): -0.22 -- --
ROI: -30.43 13.55 13.08
ROE: -31.41 14.45 14.23

BRIEF-Biohit H2 operating loss flat at EUR 1.3 mln

* H2 net sales 4.4 million euros ($4.67 million) versus 2.5 million euros year ago

Feb 20 2017

BRIEF-Biohit and R-kioski to start cooperation

* R-Kioski will sell and promote gift cards for Biohit's health checks for its consumers in R-kioski convenience stores across Finland

Nov 16 2016

BRIEF-Biohit's Chinese joint venture to start production

* Chinese joint venture Biohit HealthCare (Hefei) Co. Ltd production facility has passed official test requirements and has been granted license enabling production and sales of products

Oct 24 2016

More From Around the Web

Earnings vs. Estimates